|
Liraglutide Clinical Trials
5 actively recruiting trials across 2 locations
▲ +1 trial since August 2026
Also known as: Liraglutid, Liraglutide Acetate, Liraglutidum, Liroglutide, Saxenda +2 more
Pipeline
Phase 2: 1Phase 4: 3Phase 1/2: 1
Top Sponsors
- University of Virginia1
- The First Affiliated Hospital of Xiamen University1
- Mansa1
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1
- Biolingus1
Indications
- Diabetes5
- T2DM (Type 2 Diabetes Mellitus)1
- Maturity Onset Diabetes of the Young1
- Type 2 Diabetes Patients1
- Type2 Diabetes1
Other3 trials
Phase 4
Cincinnati, Ohio1 trial
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Cincinnati Children's Hospital Medical Center
Phase 2
Charlottesville, Virginia1 trial
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
University of Virginia
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.